Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

March 31, 2011

Study Completion Date

October 31, 2011

Conditions
SeizuresDisorder of Fetus or Newborn
Interventions
DRUG

Low dose levetiracetam

20 mg/kg loading dose; 5 mg/kg daily for 7 days.

DRUG

High dose levetiracetam

40 mg/kg IV load; 10 mg/kg/day maintenance

Trial Locations (1)

92103

University of California, San Diego Medical Center / Neonatal Intensive Care Unit (NICU), San Diego

All Listed Sponsors
collaborator

Thrasher Research Fund

OTHER

lead

Richard H. Haas

OTHER

NCT00884052 - Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures | Biotech Hunter | Biotech Hunter